To conduct investigational new drug (IND)-enabling studies of a pre-clinical candidate for the treatment of neurotropic alphaviruses.
Active Definitive Contract Awarded Last action
- Contract number
- 75N93026C00013
- Awardee
-
University Of Tennessee UEI X1M1PN3KG3E7
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,851,661
Award facts
- Opportunity
-
- 2026 NIAID DMID Omnibus Broad Agency Announcement Pre-Solicitation · HHSNIHNIAIDBAA20251 · Posted Nov 4, 2024
- Contract value 20% obligated
-
- $1,851,661.00 Current, with exercised options
- $9,349,598.00 Potential, with all options
- Completion date 13% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 20 offers Negotiated Proposal / Quote
- Pricing
- Cost No Fee
- Place of performance
- Memphis, TN 38103, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this award
The National Institute of Allergy and Infectious Diseases awarded a $9.3 million cost-no-fee definitive contract to University Of Tennessee Health Science Center on August 3, 2026, to conduct investigational new drug-enabling studies of a pre-clinical candidate for treatment of neurotropic alphaviruses.
Performance occurs in Memphis, Tennessee, with work completed by July 31, 2028. The originating solicitation was a Broad Agency Announcement (BAA) posted November 4, 2024, focused on advancing research and development of therapeutics, vaccines, and diagnostics for biodefense and emerging infectious diseases. The BAA did not restrict proposals to any specific business size or type. NAICS code 541715 (Research and Development in the Physical, Engineering, and Life Sciences) and PSC code AN12 (Health R&D Services) apply to this effort.
Quick answers
Who was awarded contract 75N93026C00013?
75N93026C00013 was awarded to University Of Tennessee by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on August 3, 2026.
How much is contract 75N93026C00013 worth?
The government has obligated $1,851,661 on 75N93026C00013. Its potential value, with all options, is $9,349,598.
Was contract 75N93026C00013 competed?
The extent of competition for 75N93026C00013 was full and open competition. The government received 20 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award